Study: Rapid treatment boosts survival odds for stroke victims

06/18/2013 | HealthDay News ·

A study in the Journal of the American Medical Association showed that the earlier a stroke patient receives clot-dissolving drugs, the better the outcome. Researchers looked at data from more than 58,000 ischemic stroke patients. Patients treated with tissue plasminogen activators within 90 minutes of symptom onset had a 26% lower risk of death and 28% reduced risk of intracranial hemorrhage than those treated within 181 to 270 minutes, for example.

View Full Article in:

HealthDay News ·

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Affairs Specialist
Becton Dickinson
Franklin Lakes, NJ
Customer Service Director
Minneapolis, MN
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Behavioral Health Operations Director
Minneapolis, MN
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID